News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Lumos Diagnostics.
RELATED STOCKHEAD STORIES
News
Small Cap Recap and IPO Wrap: Risk suddenly feels awful risky
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Anyone else feeling like they’ve heard this story somewhere before?
Health & Biotech
Check Up: Diet Coke put on notice as WHO labels artificial sweetener aspartame ‘possibly carcinogenic’
News
ASX Small Caps Lunch Wrap: Who’s got the balls to deliver a cure for cancer today?
News
Top 10 at 10: Big spodumene crystals and a +700% biotech runner
News
Rise and Shine: Everything you need to know about the day ahead
News
ASX Small Caps Lunch Wrap: Who else is thinking about taking a little time off work this decade?
News
Top 10 at 10: Stock explodes +420% on FDA approval
Health & Biotech
ASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good results
News
Top 10 at 10: Who’s finding high grade nickel today?
Experts
After scaring everyone in 2022 it looks like ASX health stocks will have a pulse in 2023
News
These were the 40 worst performing small and large capped ASX stocks in 2022
Health & Biotech
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
Health & Biotech
ASX Health Stocks: On FDA Monday Mesoblast has lifesaving evidence; Lumos hits a roadblock
Escrow Watch
ASX Escrow Watch: Spring is in the air and so is the season for releasing shares
Health & Biotech